| 1 |
Torio CM, Andrews RM. National inpatient hospital costs: the most expensive conditions by payer, 2011. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs[R]. Agency for Healthcare Research and Quality: US, 2013.
|
| 2 |
Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study[J]. Crit Care Med, 2006, 34 (2): 344-353.
|
| 3 |
Iwashyna TJ, Cooke CR, Wunsch H, et al. Population burden of long-term survivorship after severe sepsis in older Americans[J]. J Am Geriatr Soc, 2012, 60 (6): 1070-1077.
|
| 4 |
Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012[J]. Crit Care Med, 2013, 41 (2): 580-637.
|
| 5 |
Rittirsch D, Flied MA, Ward PA. Harmful molecular mechanisms in sepsis[J]. Nat Rev Immunol, 2008, 8 (10): 776-787.
|
| 6 |
Baron RM, Baron MJ, Perrella MA. Pathobiology of sepsis: are we still asking the same questions?[J]. Am J Respir Cell Mol Biol, 2006, 34 (2): 129-134.
|
| 7 |
van der Hoorn JW, de Haan W, Berbée JF, et al. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl estertransfer protein in APOE*3Leiden. CETP mice[J]. Arterioscler Thromb Vasc Biol, 2008, 28 (11): 2016-2022.
|
| 8 |
Kwon WY, Suh GJ, Kim KS, et al. Niacin attenuates lung inflammation and improvessurvival during sepsis by downregulating thenuclear factor-κB pathway[J]. Crit Care Med, 2011, 39 (2): 328-334.
|
| 9 |
Kapoor A, Shintani Y, Collino M, et al. Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock[J]. Am J Respir Crit Care Med, 2010, 182 (12): 1506-1515.
|
| 10 |
Chiu CJ, McArdle AH, Brown R, et al. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal[J]. Arch Surg, 1970, 101 (4): 478-483.
|
| 11 |
Lee SK, Yang SH, Kwon I, et al. Role of tumour necrosis factor receptor-1 and nuclear factor-κB in production of TNF-α-induced pro-inflammatory microparticles in endothelial cells[J]. Thromb Haemost, 2014, 112 (3): 580-588.
|
| 12 |
Schulte W, Bernhagen J, Bucala R. Cytokines in sepssis: potent immunoregulators and potential therapeutic targets--an updated view[J]. Mediatcors Inflamm, 2013 (2013): 165974.
|
| 13 |
Loisa P, Rinne T, Laine S, et al. Anti-inflammatory cytokine response and the development of multiple organ failure in severe sepsis[J]. Acta Anaesthesiol Scand, 2003, 47 (3): 319-325.
|
| 14 |
杨茂宪，王倩倩，沈鹏，等.免气腹单孔腹腔镜辅助盲肠结扎穿孔术建立脓毒症大鼠模型[J/CD].中华危重症医学杂志（电子版），2021，14（1）：15-19.
|
| 15 |
樊恒，乐健伟，叶继辉，等. N-乙酰半胱氨酸对脓毒症小鼠急性肾损伤的保护作用及机制研究[J/CD].中华危重症医学杂志（电子版），2021，14（3）：180-186.
|
| 16 |
Guo W, Lei J, Duan P, et al. Clinical study on application of intermittent hemofiltration combined with hemoperfusion in the early stage of severe burn in the prevention and treatment of sepsis[J]. Zhonghua Shao Shang Za Zhi, 2015, 31 (4): 248-253.
|
| 17 |
Zhu H, Xiao X, Shi Y, et al. Inhibition of miRNA-29a regulates intestinal barrier function in diarrheapredominant irritable bowel syndrome by upregulating ZO-1 and CLDN1[J]. Exp Ther Med, 2020, 20 (6): 155.
|
| 18 |
张小彬，刘丹，王妍柏，等.血清肠型脂肪酸结合蛋白和D-乳酸水平在脓毒症患者早期肠道损伤中的临床意义[J].中华危重病急救医学，2019，31（5）：545-550.
|
| 19 |
杨小娟，杨晓军，刘丹，等.脓毒症患者肠道菌群与肠屏障功能紊乱的相关性研究[J].中华急诊医学杂志，2022，31（2）：210-216.
|
| 20 |
刘以梅，居旻杰，潘思梦，等.血乳酸水平与糖尿病脓毒症患者预后的关系[J].中华危重病急救医学，2017，29（8）：689-693.
|
| 21 |
刘丹，刘伟，王晓红，等.脓毒症患者肠屏障功能损伤的临床研究[J].中华急诊医学杂志，2018，27（7）：785-789.
|
| 22 |
Reintam BA, Malbrain ML, Starkopf J, et al. Gastro-intestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems[J]. Intensive Care Med, 2012, 38 (3): 384-394.
|
| 23 |
颜骏，蔡燕，张清艳，等.脓毒症早期肠道菌群失调相关危险因素及其对预后的影响[J/CD].中华危重症医学杂志（电子版），2020，13（5）：328-333.
|
| 24 |
常雪妮，李敏，张正馨，等.维生素C在脓毒症及脓毒性休克患者治疗中疗效的Meta分析[J/CD].中华危重症医学杂志（电子版），2019，12（1）：37-41.
|
| 25 |
Ganji SH, Qin S, Zhang L, et al. Niacin inhibits vascular oxidative stress, redoxsensitive genes, and monocyte adhesion tohuman aortic endothelial cells[J]. Atherosclerosis, 2009, 202 (1): 68-75.
|
| 26 |
Gurujeyalakshmi G, Wang Y, Giri SN. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice[J]. J Pharmacol Exp Ther, 2000, 293 (1): 82-90.
|